Role of radiotherapy in diffuse large B‐cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab-Reference-Cited by-同舟云学术

Role of radiotherapy in diffuse large B‐cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

Published:2019-08-26 Issue:3 Volume:3 Page:100-104
ISSN:2398-7324
Container-title:Precision Radiation Oncology
language:en
Short-container-title:Prec. Radiat. Oncol.

Author:

Aviles Agustin¹^ORCID,Calva Angel²,Neri Natividad³,Cleto Sergio³,Silva Luis³

Affiliation:

1. Oncology Research UnitHealth Investigation CoordinationNational Medical Center IMSS Mexico City Mexico

2. Department of RadiotherapyNational Medical Center IMSS Mexico City Mexico

3. Department of HematologyOncology HospitalNational Medical Center IMSS Mexico City Mexico

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pro6.1071

Reference22 articles.

1. Benefit of Consolidative Radiation Therapy in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Chemotherapy

2. Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma With Negative Post-Chemotherapy Radiologic Imaging

3. Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma

4. Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma

5. Predictors of Local Recurrence After Rituximab-Based Chemotherapy Alone in Stage III and IV Diffuse Large B-Cell Lymphoma: Guiding Decisions for Consolidative Radiation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consolidative Radiotherapy after Complete Remission following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma Patients: A Systematic Review and Meta-Analysis;Cancers;2023-08-02

2. Multiple primary malignancies with complex genomic profiling;Current Problems in Cancer: Case Reports;2022-09

3. Dual specific CD19/CD22‑targeted chimeric antigen receptor T‑cell therapy for refractory diffuse large B‑cell lymphoma: A case report;Oncology Letters;2020-07-16

4. Radiotherapy for Non-Hodgkin Lymphomas;The Cancer Journal;2020-05